543 Results

People

  1. Schoder
    Schoder
  2. Humm
    Humm
  3. Zelenetz
    Zelenetz
  4. Lee
    Lee
  5. Moskowitz
    Moskowitz
  6. Noy
    Noy
  7. Larson
    Larson
  8. Palomba
    Palomba
  9. Yahalom
    Yahalom
  10. Horwitz
    Horwitz

Groups

  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)
  7. Survivorship Research (147)
  8. Center for Hematologic Malignancies (146)
  9. Epidemiology and Biostatistics (144)
  10. Medical Physics (144)
  1. "Heiko Schoder"
Formats
  1. Journal Article (263)
  2. Meeting Abstract (199)
  3. Book Section (31)
  4. Review (18)
  5. Editorial (14)
  6. Guidelines (8)
  7. Research Letter (6)
  8. Miscellaneous (3)
  9. Conference Paper (1)
Groups
  1. Molecular Imaging and Therapy Service (543)
  2. Radiology, Department of (543)
  3. Department of Medicine (266)
  4. GSK Faculty (161)
  5. Hematologic Malignancies, Division of (153)
  6. Sloan Kettering Institute Postdocs (153)

More Groups

People
  1. Heiko Schoder (543)
  2. John Humm (96)
  3. Steven Larson (93)
  4. Andrew Zelenetz (66)
  5. Nancy Lee (65)
  6. Alison Moskowitz (59)

More People

Years
  1. 2025 (11)
  2. 2024 (36)
  3. 2023 (42)
  4. 2022 (40)
  5. 2021 (51)
  6. 2020 (30)

More Years

Publications
  1. Journal of Nuclear Medicine (94)
  2. Journal of Clinical Oncology (60)
  3. Blood (59)
  4. International Journal of Radiation Oncology, Biology, Physics (41)
  5. European Journal of Nuclear Medicine and Molecular Imaging (38)
  6. Hematological Oncology (13)

More Publications

Publishers
  1. Society of Nuclear Medicine (94)
  2. Springer (78)
  3. Elsevier Inc. (67)
  4. American Society of Hematology (65)
  5. American Society of Clinical Oncology (60)
  6. Lippincott Williams & Wilkins (22)

More Publishers

Results (543)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Fluorodeoxyglucose (FDG) positron emission tomography (PET) as an indicator of disease progression for patients with castration-resistant metastatic prostate cancer (CRMPC)
    Meeting Abstract

    Baklajian, A.; Dennis, E. R.; Buddle, J. R.; Fox, J. J.; Schoder, H.; Morris, M. J.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • The Prostate Cancer Clinical Trials Consortium (PCCTC) bone scan data capture tool for clinical trials using Prostate Cancer Working Group 2 (PCWG2) criteria: Effect on data accuracy and workload
    Meeting Abstract

    Morris, M. J.; Farrelly, J. S.; Fox, J. J.; Dennis, E. R.; Schwartz, L. H.; Schoder, H.; Haupt, E. C.; Borwick, L. S.; Larson, S. M.; Scher, H. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Molecular imaging
    Book Section

    Larson, S. M.; Schöder, H.; Grimm, J.
    In DeVita, V. T. Jr; Lawrence, T. S.; Rosenberg, S. A. (Eds.) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 9th ed (2011)

    Fulltext@MSK | Save
  • A new phantom allowing realistic non‐uniform activity distributions for PET quantification
    Meeting Abstract

    Kirov, A. S.; Sculley, E.; Schmidtlein, C. R.; Siman, W.; Kandel, B.; Zdenek, R.; Schwar, R.; Ayzenberg, G.; Yorke, E.; Schöder, H.; more...
    Medical Physics (2011)

    Fulltext@MSK | Save
  • Interim FDG PET imaging in CALGB 50203 trial of stage I/II non-bulky Hodgkin lymphoma: Would using combined PET and CT criteria better predict response than each test alone?
    Meeting Abstract

    Kostakoglu, L.; Schoder, H.; Hall, N.; Straus, D. J.; Johnson, J. L.; Schwartz, L.; LaCasce, A.; Jung, S. H.; Bartlett, N. L.; Canellos, G. P.; more...
    Blood (2011)

    Fulltext@MSK | Save
  • Six cycles of ABVD and a negative PET scan negates the need for radiologic follow-up in early stage, non-bulky Hodgkin lymphoma: MSKCC retrospective analysis
    Meeting Abstract

    Hartridge-Lambert, S. K.; Schoder, H.; Lim, R. C.; Maragulia, J. C.; Portlock, C. S.
    Blood (2011)

    Fulltext@MSK | Save
  • Imaging of hypoxia with PET radiotracers, including, Ca-IX antibodies
    Meeting Abstract

    Schoder, H.
    European Journal of Cancer (2011)

    Fulltext@MSK | Save
  • Primary tumor metabolic volume improves risk prediction of long-term outcomes in patients with oropharyngeal squamous cell carcinoma treated with intensity modulated radiation therapy (IMRT) and chemotherapy
    Meeting Abstract

    Lim, R. C.; Schoder, H.; Eaton, A.; Gonen, M.; Rao, S.; Sherman, E.; Wong, R.; Setton, J.; Lee, N.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • A pilot study of using pre- and early (1 week) [18f]-misonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) scans as an early treatment response predictor in a series of head and neck cancer (HNC) patients undergoing chemoradiation
    Meeting Abstract

    Lee, N.; Bartlett, R.; Lian, M.; Fury, M.; Sherman, E.; Wong, R.; Zanzonico, P. B.; Schoder, H.; Humm, J.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save
  • Positron emission tomography (PET) response to initial chemotherapy and radiation therapy (RT) predicts local control in rhabdomyosarcoma
    Meeting Abstract

    Dharmarajan, K. V.; Wexler, L. H.; Tom, A.; Price, A.; Fox, J. J.; Schoder, H.; Gavane, S.; Meyers, P. A.; Wolden, S. L.
    International Journal of Radiation Oncology, Biology, Physics (2011)

    Fulltext@MSK | Save